Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer. - Borghaei H; Balli D; Paz-Ares LG; Reck M; Lu S; Ramalingam SS; Brahmer JR; John T; Carbone DP; Ciuleanu TE; Schenker M; Cobo M; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2026)